11:57 AM EST - Æterna Zentaris Inc. : reported fourth-quarter net earnings of $12.03 million U.S. or $0.19 U.S. per share versus a loss of $14.49 million U.S. or $0.27 U.S. per share a year ago. On average, three analysts polled by Thomson Reuters expected loss per share of $0.18 U.S. for the quarter. Analysts' estimate typically excludes one-time items. Revenues for the fourth quarter of 2009 grew significantly to $40.18 million U.S. from $7.24 million U.S. in the comparable period, due primarily to the company's having recognized the remaining unamortized portion, or about $30.4 million U.S., of the upfront payment received from sanofi-aventis as part of its development and marketing agreement for cetrorelix in BPH. Two analysts estimated revenues of $8.63 million U.S. for the quarter. Æterna Zentaris Inc.
shares T.AEZ are trading up $0.04 at $0.88.
